Thermo Fisher Scientific Inc. (BMV:TMO)

Market Cap	4.09T
Revenue (ttm)	802.77B
Net Income (ttm)	120.59B
Shares Out	n/a
EPS (ttm)	317.83
PE Ratio	33.93
Forward PE	25.78
Dividend	32.48 (0.30%)
Ex-Dividend Date	Dec 15, 2025

Volume	45
Average Volume	125
Open	10,760
Previous Close	n/a
Day's Range	10,760 - 10,841
52-Week Range	7,412 - 12,425
Beta	0.91
RSI	59.32
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: TMO

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD